SUDARSHAN PHARMA INDUSTRIES
Back to Income Statement
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹16 Cr | ₹11 Cr | ₹7.04 Cr | ₹5.25 Cr | ₹2.67 Cr |
What is the latest Consolidated Net Profit of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹7.04 Cr |
| Mar2022 | ₹5.25 Cr |
| Mar2021 | ₹2.67 Cr |
How is Consolidated Net Profit of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 39.28 | |
| Mar2024 | ₹11 Cr | 62.78 | |
| Mar2023 | ₹7.04 Cr | 34.09 | |
| Mar2022 | ₹5.25 Cr | 96.41 | |
| Mar2021 | ₹2.67 Cr | - | |
Compare Consolidated Net Profit of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹973.5 Cr | -4% | -4.2% | 34.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | -4% |
-4.2% |
34.9% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses